Latest Rights Issues News

ACDC Metals has rapidly expanded its Mount Jackson project in Nevada, completing an airborne geophysical survey and staking additional claims to triple the project size. The company is progressing towards drilling with fresh capital raised and a board change announced.

Tanami Gold NL (ASX:TAM) is raising $70.5 million through a fully underwritten renounceable rights issue priced at $0.06 per share, a 34.78% discount to the last traded price, to finance development of its Central Tanami Project.

Pengana International Equities (ASX:PIA) unveils a comprehensive capital management plan offering shareholders an equal-access off-market buy-back at after-tax NTA, a fully franked special dividend, and appoints Antipodes Global Investment Management to steer its portfolio.

Regener8 Resources has closed its entitlement offer, raising $1.42 million to fund the acquisition and exploration of its Srebrenica North Project, with new shares set to begin trading next week.

Aland Equity Group (ASX: AEG) reveals advanced talks on a property funds management transaction linked to its chairman, explaining recent unusual share price activity.

Evolution Energy Minerals (ASX:EV1) is set to start drilling at its Chikundo Copper Project in June 2026 despite assay delays, while progressing the Chilalo Graphite Project towards first production in October 2027 with a modular development plan and clear funding milestones.

Regener8 Resources has won shareholder approval to acquire the Srebrenica North polymetallic project in Bosnia and Herzegovina, setting the stage for its maiden exploration campaign.

Alice Queen Limited (ASX:AQX) has initiated a partially underwritten rights issue aiming to raise up to $5.77 million, with substantial shareholder Gage Resource Development committed to maintaining control. The funds will primarily support further drilling and project development at Horn Island.

Mt Malcolm Mines NL has revised its rights issue, lowering the price to $0.007 per share and adjusting the offer ratio to raise $1.81 million. The funds will support a processing plant feasibility study and advance exploration at its Leonora projects.

Fat Prophets Global Contrarian Fund (ASX: FPC) has kicked off a non-renounceable rights issue aiming to raise up to $8.45 million, with directors and a $1 million underwriter backing the offer. The capital raise is designed to boost liquidity, grow assets, and enhance market presence.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.

Fat Prophets Global Contrarian Fund (ASX: FPC) has launched an on-market buy-back of its ordinary shares, set to run from May 2026 to May 2027, signalling a fresh phase in its capital management strategy.